Bio Matters: Family influences led eyecro’s executive into scientific research

Rafal Farjo, Ph.D. is chief operating officer of both eyecro and Charlesson, which are involved in research to advance treatments for eye disease such as age-related macular degeneration, diabetic retinopathy and ocular inflammation.

Far from resisting his family’s interest in all things STEM — science, technology, engineering and math — Farjo embraced it.

“I loved it, and I actually started doing research at the University of Michigan not because I wanted to do research but because I was doing my requisite semester of research to get a letter of recommendation for medical school,” he said.

Recently, eyecro was awarded a patent for a platform technology it developed called MiDROPS. It signed a development agreement with a Seattle-based company called NeuMedics.

Read the entire article here.

Similar Posts